The cardiology sector has witnessed significant growth in the last 12 months, drawing substantial interest from private equity investors, particularly as more and more hospital employment deals continue to expire. Since the initial surge in consolidation, several new platforms have emerged, and existing ones have expanded their operations into new states. Since January 2023 there have been 22+ transactions within the cardiology space, including 3 new platforms created. While there is still plenty of white space for new platforms within Cardiology, the window to maintain a first-mover advantage is continually shrinking.
Within this evolving landscape, the sector has adapted to broader changing healthcare dynamics, as seen in other specialties. Core procedures and ancillary services continue to transition into outpatient settings, and value-based reimbursement models continue to gain traction, encouraging more physician sellers to explore partnership opportunities. Healthcare private equity investors are increasingly drawn to these models, aiming not only for improved patient outcomes and reduced costs but also for long-term sustainability and profitability.
Even despite current macroeconomic headwinds, this landscape has created an increasingly competitive environment, requiring a careful selection process for cardiology practices considering private equity partnerships. Aligning with a partner who not only understands the intricacies of the sector but also shares a vision for exceptional patient care and clinical autonomy to ensure long-term success is vital. Moreover, a partner’s expertise in service line development, navigating the reimbursement environment, infrastructure development, and geographic expansion are key factors when selecting a partner.
Interested in how private equity can help your Cardiology practice?